New studies with Sean M. Healey & AMG Center for ALS at Mass General target disease-causing gene
New studies focus on the SOD1 gene in ALS.
Healey Center News & Events
Narrow your search for a specific article by using the search box and/or filters.
52 results
A Tribute to Sean M. Healey
Two years ago, Sean M. Healey became a part of the Mass General ALS family and an advocate for those with ALS. We are saddened to share the news that Sean M. Healey, our treasured partner, patient and friend passed away peacefully May 26, 2020 with his loving family by his side.
Positive Clinical Trial Result
Peer-reviewed results of a trial led by the Healey Center’s Dr. Sabrina Paganoni, will be published soon. The CENTAUR trial, highlighted in a Wall Street Journal article, tested a drug that showed promise in slowing muscle decline in individuals with ALS.
Call for Nominations: 2020 Healey Center International Prize For Innovation In ALS
The Healey Center International Prize for Innovation in ALS is an annual global prize celebrating excellence in research for a team of investigators who catalyse exceptional discoveries leading to a transformative advance in therapy development in ALS.
新型冠状病毒疫情防控期间 ALS（肌萎缩侧索硬化）患者及护理人员注意事项
以下介绍新型冠状病毒疫情可能对ALS患者的治疗护理带来的影响。
COVID-19: Información para pacientes con ELA y sus cuidadores
Aquí hay algunas respuestas a preguntas frecuentes sobre cómo el brote del COVID-19 puede afectar su tratamiento de ELA.
HEALEY ALS Platform Trial Updates and April 8th Webinar
Please join us for a conversation about the HEALEY ALS Platform Trial on Wednesday, April 8 at 3:00 pm.
Sean M. Healey & AMG Center for ALS At Mass General Receives “May Proceed” notice for three drugs in first ALS platform trial
BOSTON – The Sean M. Healey & AMG Center for ALS at Mass General has received approval from the U.S. Food and Drug Administration (FDA) to proceed with administering three proposed drug regimens in the HEALEY ALS Platform Trial – the first trial of its kind for amyotrophic lateral sclerosis (ALS).
2020 South Florida Neuroscience Symposium
This symposium is a 2 day educational and networking forum designed for physicians,nurses, advanced practitioners, pharmacists, allied health professionals, researchers,and students with a focus on the emerging science of genetic therapies and theevaluation, management, and treatment of Alzheimer's Disease, ALS, brain tumors and metastases, and stroke.
ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial
The ALS Association today announced a $3 million commitment to the first platform trial for ALS, taking place at the Sean M. Healey & AMG Center for ALS at Mass General in collaboration with the Barrow Neurological Institute and the Northeast ALS Consortium (NEALS). A
Showing 1 - 10 of 52 results
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.